Society For Interventional Radiology Annual Meeting In Brief
This article was originally published in The Gray Sheet
Executive Summary
UFE success post-menopause: Northwestern University scientists present April 3 at the Society of Interventional Radiology's annual meeting in Toronto that uterine fibroid embolization produced symptom improvements in 22 of 25 post-menopausal women during two years of follow-up. The technique, in which tiny spherical particles are released into uterine arteries to kill fibroid tumors by blocking their blood supply, is an accepted minimally invasive first-line therapy for fibroid disease in symptomatic pre-menopausal women, but the evidence in post-menopausal women is lacking, according to the researchers...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.